Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing Between Parkinson’s Disease and Atypical Parkinsonian Syndromes

PLoS ONE- United States

doi 10.1371/journal.pone.0165869

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Substantia Nigra Hyperechogenicity in Polish Patients With Parkinson’s Disease

Folia Morphologica
AnatomyHistology
2014English

Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease

Archives of Neurology
2011English

Is 123i-Mibg Cardiac Scintigraphy a Surrogate Marker for Parkinson’s Disease?

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

The Utility of the Combined Use of 123i-Fp-Cit and 123i-Mibg Myocardial Scintigraphy in Differentiating Parkinson’s Disease From Other Parkinsonian Syndromes

Yonago Acta Medica
Medicine
2018English

Comparison Between Odor Discrimination, Substantia Nigra Echogenicity and Nigrostriatal Dopaminergic Activity Measured by 18F.PR04 Pet in Parkinsonian Syndromes

Journal of the Neurological Sciences
Neurology
2015English

Morphometry of the Human Substantia Nigra in Ageing and Parkinson’s Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2008English

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2010English

Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2015English

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease

ASN Neuro
NeuroscienceNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy